AJANTPHARM Intraday Analysis...

AJANTPHARM Share Price

Open 1155.00 Change Price %
High 1197.00 1 Day 38.30 3.32
Low 1154.55 1 Week -61.60 -4.91
Close 1191.75 1 Month -272.45 -18.61
Volume 210759 1 Year -787.05 -39.77
52 Week High 2125.00
52 Week Low 1135.00
AJANTPHARM Important Levels
Resistance 2 1231.10
Resistance 1 1214.89
Pivot 1181.10
Support 1 1168.61
Support 2 1152.40
NSE INDIA Most Active Stocks
JPASSOCIAT 21.50 2.38%
FORTIS 152.60 7.81%
INFY 892.80 1.99%
INFY 892.80 1.99%
DLF 185.95 6.08%
SINTEX 30.30 1.51%
HDIL 61.75 3.69%
UNITECH 7.30 2.10%
SUZLON 16.35 1.87%
GMRINFRA 17.20 1.18%
More..
NSE INDIA Top Gainers Stocks
NAKODA 0.30 20.00%
FMNL 101.70 20.00%
IMFA 559.70 19.99%
SALONA 65.55 19.95%
PATSPINLTD 26.95 19.51%
ZYLOG 3.45 18.97%
BLS 210.65 18.01%
SEPOWER 9.20 15.00%
SMSPHARMA 82.75 14.45%
NOIDATOLL 10.30 14.44%
More..
NSE INDIA Top Losers Stocks
ASSAMCO 5.20 -20.00%
ORCHIDPHAR 20.25 -15.27%
XLENERGY 1.65 -13.16%
PRAKASHSTL 0.35 -12.50%
JMTAUTOLTD 4.10 -9.89%
NBIFIN 3387.30 -8.70%
GRAVITA 107.50 -7.25%
QUESS 810.25 -6.84%
CCCL 4.15 -5.68%
CCCL 4.15 -5.68%
More..

Ajanta Pharma Limited (NSE: AJANTPHARM)

AJANTPHARM Technical Analysis 5
As on 23rd Aug 2017 AJANTPHARM Share Price closed @ 1191.75 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1708.50 & Strong Sell for SHORT-TERM with Stoploss of 1438.34 we also expect STOCK to react on Following IMPORTANT LEVELS.
AJANTPHARM Target for August
1st Target up-side 1510.02
2nd Target up-side 1589.13
3rd Target up-side 1668.24
1st Target down-side 1284.28
2nd Target down-side 1205.17
3rd Target down-side 1126.06
AJANTPHARM Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is Below 30 Over Sold
MFI (14) MFI is 20.40 Sideways
CCI (20) CCI is -92.86 Sideways
WILLIAM %R (14) William %R is -78.90 Sideways
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Short Sell 1263.04
10 Day Avg Volume Traded -23.64 % Less then 10 Day Average Volume
AJANTPHARM Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.ajantapharma.com
AJANTPHARM Address
AJANTPHARM
98, Ajanta House
Charkop
Mumbai, 400067
India
Phone: 91 22 6606 1000
Fax: 91 22 6606 1200
AJANTPHARM Latest News
Ajanta Pharma Ltd Fixes Record Date for Stock Split   Equity Bulls   - 12th Mar 15
Bullish on Atul Auto, Ajanta Pharma and PVR: Pankaj Pandey, ICICIdirect.com   Economic Times   - 18th Feb 15
Ajanta Pharma board approves stock split   Hindu Business Line   - 28th Jan 15
Ajanta Pharma shares soar over 12 per cent on healthy earnings   Economic Times   - 28th Jan 15
Ajanta Pharma Q3 net profit rises 38% to Rs 85 crore   Economic Times   - 28th Jan 15
Ajanta Pharma Ltd to announce Q3 results on Jan 28, 2015   Equity Bulls   - 17th Jan 15
Ajanta Pharma Announces the Launch of Risperidone Tablets   PR Newswire (press release)   - 09th May 14
Ajanta Pharma records robust growth in income, net profit   Hindu Business Line   - 27th Jan 14
Ajanta Pharma Ltd. Succeeded In Revoking Two Composition Patents Of ...   Mondaq News Alerts (registration)   - 25th Sep 13
Ajanta Pharma fixes record date for bonus Issue   Moneycontrol.com   - 06th Sep 13
Interactive Technical Analysis Chart Ajanta Pharma Limited ( AJANTPHARM NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Ajanta Pharma Limited
AJANTPHARM Business Profile
Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacture and marketing of quality finished dosages in domestic and international markets and it was established in 1973 and headquartered in Mumbai-India.The company focuses on commercializing unique generic products and synergistic combination products in the therapeutic areas of anti-malarial, Cardiovascular, dermatology, male erectile dysfunction, musculoskeletal, and ophthalmology. The company has reported a standalone sales of Rs 279.83 crore and a Net Profit of Rs 55.81 crore for the quarter ended September 2013. The Registered office is at 98, Ajanta House, Charkop, Kandivili (West), Mumbai - 400 067.